Association of Regular Cervical Cancer Screening with Socioeconomic, COVID-19 Infection and Vaccine Status Among Japanese Population: Cohort Observational Study
Tomohiro Mitoma,Jota Maki,Hikaru Ooba,Chikako Ogawa,Hisashi Masuyama,Takahiro Tabuchi
DOI: https://doi.org/10.2147/ijgm.s453675
IF: 2.145
2024-02-14
International Journal of General Medicine
Abstract:Tomohiro Mitoma, 1 Jota Maki, 1 Hikaru Ooba, 1 Chikako Ogawa, 1 Hisashi Masuyama, 1 Takahiro Tabuchi 2 1 Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Okayama, Japan; 2 Department of Cancer Control Center, Osaka International Cancer Institute, Osaka, Japan Correspondence: Jota Maki, Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan, Tel +81-86-235-7320, Fax +81-86-225-9570, Email Purpose: Among the Organisation for Economic Co-operation and Development countries, Japan has one of the lowest cervical cancer screening coverages. Cancer screening coverage has worsened due to the coronavirus disease of 2019 (COVID-19) pandemic. This study investigated the relationship between socioeconomic background, COVID-19 infection history and vaccine status, and regular cervical cancer screening (CCS) during the two years of the COVID-19 era in Japan. Patients and Methods: We used data from the Japan COVID-19 and Society Internet Survey, a nationwide, Internet-based, self-report cohort observational study conducted in 2022. The outcome variable was identified by asking whether the participants had undergone CCS within the last two years. Cervical cytology was performed in Japan by brushing the external cervical os. This study used multivariate log-binomial regression models to evaluate inequalities during regular checkups for CCS. Adjusted prevalence ratios (APRs) with 95% confidence intervals (CIs) were estimated to incorporate the socioeconomic background variables. Results: Of the 12,066 participants, 5597 (46.4%) had undergone regular CCS for over two years. The prevalence ratio (PR) of patients who underwent CCS was 0.70 for those in their 20s and 0.78 for those in their 60s, compared to those in their 40s. Socioeconomic inequities were found in the following groups: unemployed/student, unmarried, high school graduate or lower, and household income below 4 million Yen. Our final multivariate analysis revealed that participants who were in their 20s or 60s, had a household income below 4 million Yen, were unmarried, had no annual health check-ups, and were unvaccinated with COVID-19 were at a higher risk of not undergoing CCS. Conclusion: The relationship between socioeconomic inequality and CCS hesitancy is prevalent among younger participants. The CCS coverage in Japan during the COVID-19 pandemic year (2020– 2022) was not low compared with the pre-pandemic era. Keywords: cervical cancer screening, social inequality, screening hesitation, internet survey Cervical cancer screening (CCS) significantly reduces the mortality rate of cervical cancer. 1 Screening once every two years is recommended for those over 20 years old by Japan's Ministry of Health, Labor, and Welfare. Among the Organization for Economic Co-operation and Development (OECD) countries, Japan has one of the lowest CCS screening coverages, approximately half of the rate in the United States (US) and 70–80% lower than that in European countries. 2,3 The rate in 2019 was 43%, approximately 6% higher than that in 2010. However, only approximately 40% of women currently undergo regular checkups. 3 Furthermore, it is estimated that cervical cancer deaths will increase by as much as 10,000 by 2069 due to withholding the Human Papilloma Virus (HPV) vaccine in Japan. 4 Although Japan's medical system provides access to medical facilities, 5 there is still some CCS hesitancy. In Japan, the subsidy amount varies depending on the municipality of residence, but eligible individuals receive discounted screening coupons, allowing them to participate in CCS at a cost of approximately 500 to 1000 Yen. However, public surveys of general companies have identified time and financial problems as reasons for CCS hesitancy. Many published studies on the subject are questionnaire-based descriptive reports. 6,7 These have also been largely based on psychological approaches. Two of the top three responses in this study were "Because I am confident in my health condition and do not feel the need" and "Because I can visit a medical facility whenever I am worried." Moreover, criticism of obstetrics and gynecology visits from participants' acquaintances and resistance to consultations by male physicians were identified as social challenges that needed to be addressed. However, few studies have considered the social backgrounds of those who did not undergo the test. 8 The impact of coronavirus disease-19 (COVID-19) was significant in Japan. -Abstract Truncated-
medicine, general & internal